Marijuana Industry

Various enterprising companies emerging within the marketplace are providing promising ancillary investment options for those seeking to cash in on bitcoin’s rising star without investing directly in it.

India Globalization Capital, Inc. (NYSE American: IGC) sees opportunities in 2018, primarily from the distribution, in Germany, of its cannabinoid-based therapies, including IGC-AD1 (Hyalolex).

Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI), continues to add significant value to its core business model with several key movements involving a proposed merger, new licensing agreements and formation of a specialized subsidiary.

Amidst increasing awareness regarding cannabinoids and their potential health benefits, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is at the forefront of the booming cannabis industry with its patented delivery technology, DehydraTECH™.

Marijuana Company of America, Inc. (OTC: MCOA), via its wholly-owned subsidiary hempSMART, is well positioned to take advantage of this industry growth through the development and marketing of innovative hemp-derived, CBD-based nutritional and wellness products.

Through exacting scientific protocols, Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is about to radically change the understanding and applications of this millennia-old medicine.

Rade Kovacevic is a cannabis connoisseur. As the head of customer experience at Canopy Growth Corporation, a cannabis producer in Ontario, Canada, his job is to make sure his firm provides the highest quality marijuana. His company produces medicinal cannabis for patients across Canada, where recreational use is illegal but doctors can prescribe it to patients for medical purposes, such as pain management.

PotNetwork Holding, Inc. (POTN) (POTN Profile), through its Diamond CBD subsidiary, is one of the leading companies involved in the research, development and marketing of CBD-based products derived from hemp.